You are currently viewing Artificial Intelligence (AI) In Omics Studies Market Report 2026: Size, Segmentation, Regional Analysis And Key Players
Artificial Intelligence (AI) In Omics Studies Market Analysis

The Business Research Company’s 2026 market reports are designed to deliver research that is more actionable and strategically valuable. Key offerings include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.

Artificial Intelligence (AI) In Omics Studies Market Size 2026: Valuation, Growth Rate And Forecast To 2030

The market size for artificial intelligence (AI) in omics studies has witnessed significant growth in recent years. It is projected to expand from $1.23 billion in 2025 to $1.67 billion in 2026, at a compound annual growth rate (CAGR) of 35.4%. This historic growth can be attributed to several factors, including the advancement of next-generation sequencing technologies, the proliferation of bioinformatics tools, the increasing availability of biological big data, the early application of machine learning in genomics, and rising investment in life science research.

The artificial intelligence (AI) in omics studies market is projected to experience substantial expansion over the coming years. This market is forecast to reach $5.55 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 35.0%. Factors contributing to this anticipated growth include an escalating demand for precision medicine, significant progress in deep learning algorithms, the increasing integration of AI into drug discovery processes, the broadening reach of cloud-based omics platforms, and a heightened emphasis on personalized healthcare. Key trends expected during the forecast timeframe encompass AI-powered multi-omics data integration, genomic interpretation facilitated by machine learning, AI-driven prediction of protein structures, automated platforms for omics data analytics, and the identification of predictive biomarkers.

Get A Free Sample Of The Artificial Intelligence (AI) In Omics Studies Market Report 2026:

https://thebusinessresearchcompany.com/sample_request?id=11345537&type=smp&name=Artificial%20Intelligence%20%28AI%29%20In%20Omics%20Studies%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

What Is Driving The Growth Of The Artificial Intelligence (AI) In Omics Studies Market?

The expanding need for personalized medicine is anticipated to drive the advancement of artificial intelligence in the omics studies market in the future. Personalized medicine involves customizing medical care to suit the unique attributes of every patient. This approach enhances treatment effectiveness and reduces negative side effects by taking into account genetic, environmental, and lifestyle elements. The growing adoption of personalized medicine stems from progress in genomic medicine, enhanced diagnostic instruments, and healthcare strategies guided by data. Artificial intelligence in omics studies strengthens personalized medicine by offering deeper understanding of diseases at a molecular level, refining treatment accuracy, and ultimately contributing to superior patient results. An illustration of this trend is that in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA granted approval to 16 new personalized treatments for rare disease patients in 2023, representing a significant increase from the 6 approvals in 2022. Consequently, the rising demand for personalized medicine propels the expansion of artificial intelligence in omics studies.

How Is The Artificial Intelligence (AI) In Omics Studies Market Segmented?

The artificial intelligence (AI) in omics studies market covered in this report is segmented –

1) By Offering: Software, Services

2) By Technology Platform: Sequencing, Epigenomics, Proteomics, Metabolomics, Other Technologies

3) By Application: Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Other Applications

4) By End-User: Academic And Research Institutes, Biopharmaceutical Company, Other End-Users

Subsegments:

1) By Software: AI-Powered Data Analytics Software, Omics Data Integration Software, Machine Learning Platforms for Genomics, AI-Based Protein Structure Prediction Software, AI-Based Drug Discovery Software, AI for Metabolomics Analysis Tools, AI-Driven Genome Sequencing Software, Bioinformatics Software for Multi-Omics Data

2) By Services: AI-Based Data Analysis Services, Consulting Services for AI in Omics, AI Model Development and Customization Services, Omics Data Management and Interpretation Services, AI-Driven Drug Discovery and Development Services, Cloud-Based Omics Data Storage and Processing Services, AI-Based Omics Training and Support Services

What Are The Latest Trends In The Artificial Intelligence (AI) In Omics Studies Market?

Leading companies operating in the artificial intelligence in omics studies market are focusing on creating advanced solutions, such as cloud-based platforms leveraging the concept of data federation to improve data sharing and collaboration across different research institutions. This allows for smooth integration and analysis of extensive omics data from various sources while maintaining data privacy and security. These cloud platforms consolidate diverse omics data types, including genomics, proteomics, and metabolomics, and employ machine learning algorithms to analyze this data and derive valuable insights. For instance, in September 2023, DNAstack, a Canada-based biotechnology company, unveiled Omics AI, an innovative software suite specifically designed to accelerate omics research. The key features of Omics AI include its capability to process large datasets, deliver real-time analytics, and foster collaboration among researchers worldwide. This innovation boosts the efficiency of omics studies, although it also raises issues regarding data privacy and the necessity for strong cybersecurity measures to safeguard sensitive genetic information.

Who Are The Key Players In The Artificial Intelligence (AI) In Omics Studies Market?

Major companies operating in the artificial intelligence (AI) in omics studies market are Amazon.com Inc. , Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, General Electric Company, Agilent Technologies Inc., Koninklijke Philips N.V., Dassault Systemes SA, Illumina Inc., Fujifilm Holdings Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Canon Medical Systems Corporation, Bruker Corporation, Qiagen N.V., BGI Genomics Co Ltd., Takara Bio Inc., Elekta AB

Read The Complete Artificial Intelligence (AI) In Omics Studies Market Report 2026:

https://thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-omics-studies-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Which Region Is The Largest In The Artificial Intelligence (AI) In Omics Studies Market?

North America was the largest region in the artificial intelligence in omics studies market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in omics studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model